Equities

Global Medical REIT Inc

Global Medical REIT Inc

Actions
  • Price (EUR)7.69
  • Today's Change0.135 / 1.79%
  • Shares traded0.00
  • 1 Year change-4.35%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Global Medical REIT Inc. is an internally managed real estate investment trust (REIT). The Company acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. The Company conducts its business through a wholly owned subsidiaries of its operating partnership, Global Medical REIT L.P. It owns 92.91% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 7.09% of the Operating Partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the operating partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospital and others. The Company's portfolio is located in various areas, including Texas, Florida, Ohio, Oklahoma, Pennsylvania, Arizona, and Illinois.

  • Revenue in USD (TTM)141.05m
  • Net income in USD14.79m
  • Incorporated2014
  • Employees26.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.